ELV · Elevance Health, Inc. · Executive Compensation

$396.90 -5.04 (-1.25%) At close · Sep 9

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$87.17B

216.87M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gail Boudreaux	President and Chief Executive Officer (CEO)	$1,600,000	—	$13,440,277	$4,199,765	$2,768,000	$574,272	$22,582,314
Mark Kaye	EVP and Chief Financial Officer (CFO)	$938,462	—	$4,560,511	$1,424,506	$974,123	$94,475	$7,992,077
Peter D. Haytaian	EVP and President, Carelon and CarelonRx	$950,000	—	$3,840,306	$1,199,710	$986,100	$122,372	$7,098,488
Felicia Norwood	EVP and Chief Health Benefits Officer	$950,000	—	$3,840,306	$1,199,710	$986,100	$97,849	$7,073,965
Morgan Kendrick	EVP and President, Commercial and Specialty Health Benefits	$888,462	—	$3,600,237	$1,124,813	$922,223	$102,759	$6,661,911

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gail Boudreaux	President and Chief Executive Officer (CEO)	$1,600,000	—	$12,600,032	$4,199,989	$1,142,400	$929,555	$20,471,976
Mark Kaye	EVP and Chief Financial Officer (CFO)	$900,000	—	$4,125,144	$1,374,953	$385,560	$87,487	$6,873,144
Peter D. Haytaian	EVP and President, Carelon and CarelonRx	$950,000	—	$3,600,081	$1,199,997	$406,980	$188,069	$6,345,127
Felicia Norwood	EVP and President, Government Health Benefits	$950,000	—	$3,600,081	$1,199,997	$406,980	$131,888	$6,288,946
Morgan Kendrick	EVP and President, Commercial and Specialty Health Benefits	$850,000	—	$3,225,249	$1,074,825	$510,000	$133,400	$5,793,474

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gail Boudreaux	President and Chief Executive Officer (CEO)	$1,600,000	—	$11,850,043	$3,950,036	$3,648,000	$840,960	$21,889,039
Mark Kaye	EVP and Chief Financial Officer (CFO)	$252,692	$2,500,000	$10,775,411	$924,613	$351,748	$54,737	$14,859,201
Mark B. Kaye	EVP and Chief Financial Officer (CFO)	$252,692	—	$10,775,411	$924,613	$351,748	$54,737	$12,359,201
John Gallina	Former EVP and Chief Financial Officer (CFO)	$944,231	—	$4,312,731	$1,437,286	$1,314,369	$144,881	$8,165,416
Blair Todt	EVP, Chief Legal and Administrative Officer	$833,846	—	$5,000,648	$999,708	$1,155,711	$123,059	$8,112,972
Peter D. Haytaian	EVP and President, Carelon and CarelonRx	$944,231	—	$3,225,051	$1,074,976	$1,314,369	$419,424	$6,978,051
Felicia Norwood	EVP and President, Government Health Benefits	$944,231	—	$3,225,051	$1,074,976	$1,087,754	$143,396	$6,475,408

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gail Boudreaux	President and Chief Executive Officer (CEO)	$1,600,000	—	$11,100,128	$3,699,929	$3,840,000	$691,024	$20,931,081
John Gallina	Former EVP and Chief Financial Officer (CFO)	$919,231	—	$3,937,532	$1,312,557	$1,323,692	$148,825	$7,641,837
Gloria M. McCarthy	EVP and Chief Administrative Officer	$919,231	—	$3,000,218	$999,871	$1,213,385	$138,988	$6,426,376
Peter D. Haytaian	EVP and President, Carelon and CarelonRx	$919,231	—	$3,000,218	$999,871	$1,323,692	$144,717	$6,387,729
Felicia Norwood	EVP and President, Government Health Benefits	$919,231	—	$3,000,218	$999,871	$1,323,692	$143,975	$6,386,987

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gail Boudreaux	President and Chief Executive Officer (CEO)	$1,561,538	—	$9,900,081	$3,299,986	$4,019,399	$567,237	$19,348,241
Peter D. Haytaian	EVP and President, Carelon and CarelonRx	$890,385	—	$4,125,385	$1,374,662	$1,375,111	$123,315	$7,888,858
John Gallina	Former EVP and Chief Financial Officer (CFO)	$890,385	—	$2,812,665	$937,402	$1,375,111	$123,315	$6,141,280
Gloria M. McCarthy	EVP and Chief Administrative Officer	$890,385	—	$2,625,154	$874,893	$1,260,519	$123,315	$5,923,134
Felicia Norwood	EVP and President, Government Health Benefits	$880,769	—	$2,625,154	$874,893	$1,360,260	$92,861	$5,833,937

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gail Boudreaux	President and Chief Executive Officer (CEO)	$1,400,000	—	$9,000,196	$2,999,847	$3,270,800	$439,109	$17,109,952
Gloria M. McCarthy	EVP and Chief Administrative Officer	$845,192	—	$2,437,632	$812,385	$1,183,269	$108,871	$5,530,661
John Gallina	EVP and Chief Financial Officer (CFO)	$845,192	—	$2,437,632	$812,385	$1,183,269	$109,773	$5,401,735
Peter D. Haytaian	EVP and President, Carelon and CarelonRx	$845,192	—	$2,437,632	$812,385	$1,183,269	$108,633	$5,387,111
Felicia Norwood	EVP and President, Government Business Division	$785,577	—	$2,437,632	$812,385	$1,099,808	$101,001	$5,236,403

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Gail Boudreaux	President and Chief Executive Officer (CEO)	$1,400,000	—	$8,362,743	$2,787,303	$2,695,000	$228,093	$15,473,139
Felicia Norwood	EVP and President, Government Business Division	$720,192	—	$5,662,903	$687,361	$792,211	$60,088	$7,922,755
Gloria M. McCarthy	EVP and Chief Administrative Officer	$825,000	—	$2,437,749	$812,264	$907,500	$126,724	$5,247,126
John Gallina	EVP and Chief Financial Officer (CFO)	$820,192	—	$2,437,749	$812,264	$902,211	$118,954	$5,109,053
Peter D. Haytaian	EVP and President, Diversified Business Group and IngenioRx	$820,192	—	$2,437,749	$812,264	$902,211	$104,550	$5,076,966

Executive changes

Person	Role	Change	Effective	Filed
Amy W. Schulman	independent director	Appointed	2026-01-12	2025-12-10
Steven H. Collis	independent director	Appointed	2025-08-01	2025-07-28

Key facts CIK 1156039 CUSIP 036752103 13F (30d) 674 filings 635 filers Visit website Investor relations